Revvity | PKI - Vertriebs- Und Verwaltungskosten

Aktienkurs
86.77
Täglich Wechseln
-0.38 -0.44%
Monatlich
-1.22%
Jährlich
-7.98%
Q2 Prognose
84.91




Vertriebs- Und Verwaltungskosten Veränderung Datum
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
Bio Techne USD 113.69M 2.52M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Bruker USD 247.2M 4.7M 2025-12
Celltrion KRW 249.98B 16.36B 2025-09
Charles River Laboratories USD 196.14M 18.55M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 383M 28M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Illumina USD 283M 27M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
IQVIA Holdings USD 468M 46M 2025-12
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Laboratory Of America USD 538.6M 13.8M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Pharma Mar EUR 17.31M 3.6M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Quidel USD 194.4M 7.5M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Tilray USD 24.85M 1.7M 2025-09
Waters USD 240.01M 25.78M 2025-12
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09